Template:PDB Gallery/6714

• 
  1a07: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-MALONYL TYR-GLU-(N,N-DIPENTYL AMINE)
• 
  1a08: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-DIFLUORO PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)
• 
  1a09: C-src (SH2 domain) complexed with ace-formyl phosphotyr-glu-(n,n-dipentyl amine)
• 
  1a1a: C-SRC (SH2 DOMAIN WITH C188A MUTATION) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)
• 
  1a1b: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)
• 
  1a1c: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N-ME(-(CH2)3-CYCLOPENTYL))
• 
  1a1e: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(3-BUTYLPIPERIDINE)
• 
  1bkl: SELF-ASSOCIATED APO SRC SH2 DOMAIN
• 
  1bkm: COCRYSTAL STRUCTURE OF D-AMINO ACID SUBSTITUTED PHOSPHOPEPTIDE COMPLEX
• 
  1f1w: SRC SH2 THREF1TRP MUTANT COMPLEXED WITH THE PHOSPHOPEPTIDE S(PTR)VNVQN
• 
  1f2f: SRC SH2 THREF1TRP MUTANT
• 
  1fmk: CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC
• 
  1hcs: NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX
• 
  1hct: NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX
• 
  1is0: Crystal Structure of a Complex of the Src SH2 Domain with Conformationally Constrained Peptide Inhibitor
• 
  1kc2: structure of the triple (Lys(beta)D3Ala, Asp(beta)C8Ala, AspCD2Ala) mutant of the Src SH2 domain bound to the PQpYEEIPI peptide
• 
  1ksw: Structure of Human c-Src Tyrosine Kinase (Thr338Gly Mutant) in Complex with N6-benzyl ADP
• 
  1nlo: STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE
• 
  1nlp: STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE
• 
  1nzl: Crystal Structure of Src SH2 domain bound to doubly phosphorylated peptide PQpYEpYIPI
• 
  1nzv: Crystal Structure of Src SH2 domain bound to doubly phosphorylated peptide PQpYIpYVPA
• 
  1o41: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78300.
• 
  1o42: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU81843.
• 
  1o43: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82129.
• 
  1o44: Crystal structure of sh2 in complex with ru85052
• 
  1o45: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU84687.
• 
  1o46: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU90395.
• 
  1o47: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82209.
• 
  1o48: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85053.
• 
  1o49: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85493.
• 
  1o4a: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82197.
• 
  1o4b: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU83876.
• 
  1o4c: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE.
• 
  1o4d: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78262.
• 
  1o4e: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78299.
• 
  1o4f: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79073.
• 
  1o4g: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH DPI59.
• 
  1o4h: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79072.
• 
  1o4i: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PAS219.
• 
  1o4j: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH ISO24.
• 
  1o4k: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PASBN.
• 
  1o4l: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH FRAGMENT2.
• 
  1o4m: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH MALONICACID.
• 
  1o4n: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH OXALIC ACID.
• 
  1o4o: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHENYLPHOSPHATE.
• 
  1o4p: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78791.
• 
  1o4q: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79256.
• 
  1o4r: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78783.
• 
  1p13: Crystal Structure of the Src SH2 Domain Complexed with Peptide (SDpYANFK)
• 
  1prl: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS
• 
  1prm: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS
• 
  1qwe: C-SRC SH3 DOMAIN COMPLEXED WITH LIGAND APP12
• 
  1qwf: C-SRC SH3 DOMAIN COMPLEXED WITH LIGAND VSL12
• 
  1rlp: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS
• 
  1rlq: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS
• 
  1sha: CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES
• 
  1shb: CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES
• 
  1shd: PEPTIDE INHIBITORS OF SRC SH3-SH2-PHOSPHOPROTEIN INTERACTIONS
• 
  1skj: COCRYSTAL STRUCTURE OF UREA-SUBSTITUTED PHOSPHOPEPTIDE COMPLEX
• 
  1spr: BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
• 
  1sps: BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
• 
  1srl: 1H AND 15N ASSIGNMENTS AND SECONDARY STRUCTURE OF THE SRC SH3 DOMAIN
• 
  1srm: 1H AND 15N ASSIGNMENTS AND SECONDARY STRUCTURE OF THE SRC SH3 DOMAIN
• 
  1y57: Structure of unphosphorylated c-Src in complex with an inhibitor
• 
  1yi6: C-term tail segment of human tyrosine kinase (258-533)
• 
  1yoj: Crystal structure of Src kinase domain
• 
  1yol: Crystal structure of Src kinase domain in complex with CGP77675
• 
  1yom: Crystal structure of Src kinase domain in complex with Purvalanol A
• 
  2bdf: Src kinase in complex with inhibitor AP23451
• 
  2bdj: Src kinase in complex with inhibitor AP23464
• 
  2h8h: Src kinase in complex with a quinazoline inhibitor
• 
  2hwo: Crystal structure of Src kinase domain in complex with covalent inhibitor
• 
  2hwp: Crystal structure of Src kinase domain in complex with covalent inhibitor PD168393
• 
  2oiq: Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.
• 
  2ptk: CHICKEN SRC TYROSINE KINASE
• 
  2src: CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP